Explore the field of growth-hormone-releasing hormone analogues. This No DAC material must be distinguished from the long-acting preparation used in the linked human studies.
Research use only
Not for human or animal consumption. No medical use or self-administration.
Growth-hormone-releasing hormone analogues Formulation evidence gap
What it is and why it is studied
Growth-hormone-releasing hormone research asks how signalling at the pituitary controls growth hormone and IGF-1. CJC-1295 names appear frequently in this field, but the preparation used in each experiment matters.
What studies have found
The linked human studies measured hormone responses to long-acting, albumin-binding CJC-1295. They provide background to the research area; they did not test a material labelled CJC-1295 without DAC.
Confirm the peptide sequence and formulation of this No DAC material before selecting a study model. Duration of action and outcomes reported for the DAC preparation cannot be assigned to it.
The No DAC label does not by itself confirm the exact sequence or chemical modifications. No formula, molar mass or CAS is assigned until the supplied identity is confirmed. The linked clinical studies used long-acting, albumin-binding CJC-1295.
Selected literature and reference information checked 11 September 2026. Study findings concern the preparations and models described; they do not certify this product. For laboratory research only.
Additional information
Strength
2 mg
Reviews
There are no reviews yet.
Be the first to review “CJC-1295 (No DAC)” Cancel reply
Related listings are for catalogue browsing. They do not confirm compatibility or suitability for combined use; check product-specific supplier documentation.
Reviews
There are no reviews yet.